MAPT and neurodegenerative disease: An electrochemical immunosensor platform based on gold nanoparticles and polyamidoamine (PAMAM) dendrimer, screen-printed carbon electrodes were developed for accurate and specific identification of tau protein in biological samples as well as brain tissues suffering neurodegenerative diseases.